Medhealth Review

Candida auris, Latest Worry for the U.S. Healthcare

Candida auris, a presumably deadly fungal infection, is a cause of worry for healthcare experts across the U.S. 

As per the U.S Centers for Disease Control and Prevention, cases of Candida auris fungal infections are nearly doubling between 2020 and 2021 in U.S. healthcare facilities.

CDC researchers examined how the Candida auris fungus spread in American healthcare facilities between 2019 and 2021. Their findings were published in a recent research paper. 

READ MORE: Team of Researchers at Rice University Develops A New Device for Disabled People

According to CDC recommendations, the most typical symptoms of Candida auris are  high fever and chills that persist even after treatment. However, a severe infection can often show aggravated signs.

The sickest hospital patients are at risk from the fungus Candida auris. Because the fungus has developed resistance to antifungal medications, infection with it can be fatal.

Between 30 and 60% of those infected with this fungus have died, according to the CDC. However, some of them were suffering from complicated illnesses as well.

READ MORE: Can Clinical Research and the Code of Ethics Coexist?

Those who are incredibly ill, use invasive medical equipment like mechanical ventilators, or have prolonged or frequent hospital stays are particularly vulnerable to infections.

Candida auris has now been found in more than half of U.S. states, despite initially being mostly restricted to the metropolitan areas of New York City and Chicago. 

Infection was initially identified in the U.S. in 2016. However, according to CDC data published in the Annals of Internal Medicine, the most pronounced increase in cases occurred between 2020 and 2021.

Must Read
- Advertisement -spot_img
Related Articles